Home › Soft Tissue Sarcoma › Virginia › Arlington
Soft Tissue Sarcoma clinical trials in Arlington, VA
5 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- Next Oncology Virginia, Fairfax · 11 mi away
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RecruitingPhase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi away
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RecruitingPhase 1/2
- NEXT Oncology, Fairfax · 11 mi away
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
RecruitingPhase 1
- Zai Lab Site 02006, Fairfax · 11 mi away
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
About Soft Tissue Sarcoma
Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available
More about Soft Tissue Sarcoma on MedlinePlus
Soft Tissue Sarcoma trials in other cities
- Houston, TX32 studies
- New York City, NY20 studies
- Boston, MA18 studies
- St. Louis, MO14 studies
- Los Angeles, CA13 studies
- Columbus, OH13 studies
- Washington, DC12 studies
- Memphis, TN11 studies
- Philadelphia, PA10 studies
- Queens, NY9 studies
- Rochester, MN9 studies
- Aurora, CO9 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)49 studies
- Breast Cancer46 studies
- Ovarian Cancer45 studies
- Lung Cancer40 studies
- Endometrial Cancer38 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma25 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.